Skip to main content

Table 2 Recipient and transplant data

From: Neutrophil gelatinase-associated lipocalin does not originate from the kidney during reperfusion in clinical renal transplantation

 

ALL [N = 28 (100%)]

NO-DGF [N = 22 (79%)]

DGF [N = 6 (21%)]

Age (years)

57 (48–64)

56 (45–62)

62 (54–67)

Male gender

20 (71%)

14 (64%)

6 (100%)

Body mass index (kg/m2)

25 (23–28)

25 (23–27)

25 (21–30)

Cause of ESRD

 Polycystic kidney disease

10 (36%)

8 (36%)

2 (33%)

 Glomerulonephritis

7 (25%)

4 (18%)

3 (50%)

 Diabetes

6 (21%)

6 (27%)

0 (0%)

 Other

5 (18%)

4 (18%)

1 (16.7%)

Time on dialysis (months)

20 (10–38)

19 (10–37)

28 (11–65)

Haemodialysis

20 (71%)

14 (64%)

6 (100%)

Peritoneal dialysis

8 (29%)

8 (36%)

0 (0%)

Time on waiting list (months)

11 (4–26)

10 (3–24)

22 (4–37)

Plasma creatinine (µmol/l) at

 1 week after transplant

176 (135–294)

171 (117–223)

580 (265–723)*

 1 month after transplant

144 (112–223)

125 (106–175)

211 (188–317)*

 3 months after transplant

125 (109–174)

120 (102–172)

155 (143–194)†

Cold ischaemia time (h)

18.7 (15.2–21.7)

19.1 (17.8–21.9)

15.5 (13.0–21.0)

Warm ischaemia time (h)a

54 (48–69)

54 (46–69)

60 (49–91)

Rejection at 3 months

4 (14%)

2 (9%)

2 (33%)

  1. Data are median (interquartile range) or number (percentage). aData missing from three no-DGF transplants; †p < 0.05 and *p < 0.01 for DGF vs. NO-DGF. DGF Delayed Graft Function. ESRD end-stage renal disease